The Impact of the COVID-19 Pandemic on End-of-Life Prescribing in Ontario Nursing Homes.

Main Article Content

Christina Milani
Colleen Webber
Anna Clarke
Sarina Isenberg
James Downar
Daniel Kobewka
Amy Hsu
Jenny Lau
Aynharan Sinnarajah
Jessica Simon
Kaitlyn Boese
Amit Arya
Rhiannon Roberts
Luke Turcotte
Michelle Howard
Colleen Maxwell
Benoit Robert
Peter Tanuseputro


Our preliminary work revealed significant variations in the prescribing of end-of-life symptom management medications in nursing homes prior to the onset of the COVID-19 pandemic. In this study, we sought to explore whether the prescribing of end-of-life medications in nursing homes changed with the onset of the pandemic.

This was a retrospective cohort study of nursing home residents age 65+ who died in Ontario, Canada, divided into two time periods based on death date: pre-COVID-19 (January 1st, 2017 – March 17th, 2020) and during COVID-19 (March 18th, 2020 – March 31st, 2021). Using routinely collected health administrative data and our evidence-based end-of-life medications list, we linked resident data to prescription claims to identify whether residents were prescribed these medications in the last 14 days of life. We grouped homes into quintiles according to the proportion of decedents who received ≥1 prescription and examined changes in prescribing before and during COVID-19.

Nursing homes in the lowest prescribing quintile prescribed, on average, 11.5% fewer end-of-life symptom management medications during COVID-19 compared to pre-pandemic. Conversely, homes in the highest quintile prescribed an average of 13.7% more medications during COVID-19. Nursing homes in the lowest quintile had more COVID-19-positive residents (33% of residents) compared to homes in the highest quintile (9% of residents). Additionally, nursing homes in the lowest prescribing quintile spent more time with active COVID-19 outbreaks compared to homes in the highest quintile (mean 72.7 days versus 24.1 days, respectively, standardized difference 0.819).

The COVID-19 pandemic has disproportionately impacted nursing homes across Canada. Our findings suggest that nursing homes with low rates of prescribing of end-of-life medications prior to the pandemic had even lower prescribing rates during the pandemic. These homes were also harder hit by COVID-19 infections and outbreaks.

Article Details

How to Cite
Milani, C., Webber, C., Clarke, A., Isenberg, S., Downar, J., Kobewka, D., Hsu, A., Lau, J., Sinnarajah, A., Simon, J., Boese, K., Arya, A., Roberts, R., Turcotte, L., Howard, M., Maxwell, C., Robert, B. and Tanuseputro, P. (2022) “The Impact of the COVID-19 Pandemic on End-of-Life Prescribing in Ontario Nursing Homes”., International Journal of Population Data Science, 7(3). doi: 10.23889/ijpds.v7i3.2064.

Most read articles by the same author(s)

1 2 > >>